Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Barnette, R. E.
space
  arrow  Carlsson, C.
space
 arrow  PubMed                        
space

LETTER

Prolonged Weakness and Vecuronium

right arrow Rodger E. Barnette and Christer Carlsson

1 April 1993 | Volume 118 Issue 7 | Pages 569-571


TO THE EDITOR:

As Kupfer and colleagues [1] note, most patients in the intensive care unit do not require complete neuromuscular blockade. Their statement, however, that "a 75% blockade is usually sufficient" and that the degree of blockade should be monitored bears comment.

Neuromuscular function is usually evaluated in the intensive care unit by the response of the adductor pollicis brevis muscle (adduction of thumb) to percutaneous supramaximal stimulation of the ulnar nerve, using skin electrodes placed at the wrist and connected to a peripheral nerve stimulator. The ratio of a single twitch to that of a control twitch reflects the extent of neuromuscular receptor occupancy by a nondepolarizing neuromuscular blocking agent (that is, 80% reduction in twitch height is equivalent to 80% blockade). If train-of-four stimulation is used, successive twitches disappear as progressively greater degrees of neuromuscular blockade are achieved. Over the range of 75% to 100% blockade, the fourth, third, second, and first twitches become inappreciable, in that order; spontaneous recovery occurs predictably in reverse order [2].

Clinically relevant blockade of neuromuscular transmission begins at a 75% receptor occupancy by a neuromuscular blocking agent. In a study examining the margin of safety in neuromuscular transmission in cats, using single-twitch stimulation, Paton and Waud [3] found that 75% of the acetylcholine receptors must be blocked before neuromuscular transmission begins to fail. The presence of one or two responses to train-of-four stimulation indicates acceptable neuromuscular blockade during most abdominal procedures [4]. Ablation of more than three twitches to train-of-four stimulation is usually unnecessary in the critically ill patient [5].

It is important to keep in mind that the diaphragm is the most resistant of all muscles to the action of neuromuscular blocking agents. It requires 1.4 to 2.0 times as much agent as the adductor pollicis brevis muscle for identical degrees of paralysis [4]. Thus, if all diaphragmatic motion must be stopped, it is necessary to increase the degree of the neuromuscular blockade. In such situations, using the post-tetanic count [4] rather than train-of-four stimulation may enable the critical care practitioner to estimate the amount of time necessary for recovery from blockade.

We wish to re-emphasize that all patients receiving this drug (or any other nondepolarizing neuromuscular blocking agent) by continuous infusion in the intensive care unit should have the intensity of their neuromuscular blockade monitored with a peripheral nerve stimulator, based on an understanding of how peripheral nerve stimulation correlates with receptor occupancy.


References
space
up arrowTop
dotReferences

1. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged weakness after long-term infusion of vecuronium bromide. Ann Intern Med. 1992; 117:484-6.

2. Lee CM. Train of four quantitation of competitive neuromuscular blockade. Anesth Analg. 1975; 54:649-53.

3. Paton ED, Waud DR. The margin of safety of neuromuscular transmission. J Physiol (Lond). 1967; 191:59-90.

4. Mogensen V. Neuromuscular monitoring. In: Miller RD; ed. Anesthesia. 3rd edition. New York: Churchill Livingstone; 1209-26.

5. Fiamengo SA, Savarese JJ. Use of muscle relaxants in intensive care units. Crit Care Med. 1991; 19:1457-9.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Barnette, R. E.
space
  arrow  Carlsson, C.
space
 arrow  PubMed                        
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online